Gilead hires Dietmar Berger as CMO

Gilead Sciences Inc. (NASDAQ:GILD) has found its successor to Merdad Parsey as CMO in Dietmar Berger, the former CMO and global head of development at Sanofi (Euronext:SAN; NASDAQ:SNY). Berger has held senior roles at three other large biopharmas: Amgen Inc. (NASDAQ:AMGN), Bayer AG (Xetra:BAYN) and Genentech Inc.

Tanya Wallace has left Neumora Therapeutics Inc. (NASDAQ:NMRA) for  AbbVie Inc. (NYSE:ABBV), where she is now VP, head of neuroscience and ophthalmology discovery research...